about
CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritisBAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growthTTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activationCutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergyFollicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin productionNF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytesLPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microgliaCell fate decision: T-helper 1 and 2 subsets in immune responses.The microglial "activation" continuum: from innate to adaptive responsesAtherosclerosis: a chronic inflammatory disease mediated by mast cellsAdeno-associated Virus as a Mammalian DNA VectorAntibodies in the pathogenesis of hypertensionThe signaling role of CD40 ligand in platelet biology and in platelet component transfusionThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisSorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?CD40 immunotherapy for pancreatic cancermTOR kinase inhibitors as potential cancer therapeutic drugsInhibition of Autoimmune Diabetes in NOD Mice by miRNA TherapyRibavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivoEliminating Schistosomes through Vaccination: What are the Best Immune Weapons?Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasiaCD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infectionMolecular characterization of CD40 signaling intermediatesMonoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in micePotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseaseCD154-CD40 interactions in the control of murine B cell hematopoiesisAn antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejectionNuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activityT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesCD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanismsAcute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.Emerging drugs for chronic lymphocytic leukaemia.Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.Separable effector T cell populations specialized for B cell help or tissue inflammation.A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.Role of CD40-CVD40L in mouse severe malaria.Characterization of pancreatic ductal cells in human islet preparations.Ex vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 phase I trial
P2860
Q21285053-F3154C76-C391-45E4-9E13-C5A5EFB34395Q22009942-02E4A52D-3A28-4310-AEA6-9B692BBDC736Q22253885-095DCF47-869C-46AC-AB18-071AEF429E26Q24597077-D3CD7611-830F-41C9-87C0-EF873D8CC3F5Q24676570-0F1A5894-0960-433F-8E5E-E297632B8AC4Q24685661-EA7B7261-1FDD-40A4-9506-EA72293DE2AEQ24685951-66A182E1-6856-494D-A594-C8EDC4C526F1Q24806926-D9A36361-2F3F-4296-AF0D-802D42CEDE90Q24814335-AC608757-5A2A-4CF8-98E7-0E60BAE32192Q26773173-426E4237-0A37-48CD-8519-2E361BAE2630Q26782605-AAD8FAAA-4F60-492C-A6D7-5C042F8F7E5CQ26828588-DA3D9227-45B2-4DC6-B137-5C9E10ECBFDDQ26863134-668621FD-BC33-4F4A-A8C2-E40AE1F54E28Q26996707-CA6946E4-E007-4FFE-B55B-C1A565C599ECQ27002575-41A142A8-FDD4-455C-A58D-A23E200F0431Q27012550-FEE65286-AB2D-4021-927F-8FA2D2CBFE34Q27027963-DEF5A7E7-D187-4877-918F-44A63A786608Q27334532-0213D424-F9D1-424E-82AB-225803E80F3CQ27480732-B2047D6A-C853-4069-BAD3-CFB4B375779AQ28081158-B30DB225-5E6B-4881-B009-22B8C9566BC9Q28202460-77DC7C94-51E0-4839-BB53-52C3BB9A802EQ28203801-6ADF6E02-1670-45F2-9D11-61AE29C8F34FQ28216544-25FAC883-26C4-419A-9C2E-A1427B5DBA52Q28250644-8CF3246D-0700-4FEC-865A-DB57BD1F6114Q28252713-1B6112B6-22EA-4583-BD0E-9678AF2BABEDQ28305580-DD49311B-D543-4E05-8CFC-C57F68BAA79BQ28349898-4A1B189B-968F-4E86-B698-77E16500F596Q28383134-4BDDC520-A76B-416D-A26B-4C35FE9A352CQ28396774-27775C4B-4BAC-4CE3-A6EF-E4D208BB930CQ28533954-E0692D43-E2B3-4DCE-B7B2-4240DEF83774Q30275560-5E90BE94-35B2-489B-8F50-7976F26E81BDQ30353154-FB963023-5495-4BFA-A29E-C4118613176BQ31100421-E506A0CE-BC0B-4DB5-97D5-296B0D0B02B2Q31139732-60EDE3DA-161F-47D2-B74C-AB3EE64CC734Q33182376-C0A01769-2411-475A-9662-489513927F1DQ33193416-223BD1E0-6397-4E8C-85CF-770E094866B9Q33250086-2A9D74BE-D977-45F6-9A83-0C26415BA8FDQ33338408-B96075F8-A614-4E92-83B2-583F9B935EA2Q33367926-86B0C743-8516-4992-9F46-426048689DF6Q33557015-43DA1C1B-3C0B-4904-8221-1E306EF4E6CC
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@ast
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en-gb
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@nl
type
label
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@ast
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en-gb
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@nl
altLabel
CD40 and CD154 in cell-mediated immunity
@en
prefLabel
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@ast
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en-gb
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@nl
P3181
P1476
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
@en
P2093
Iqbal S. Grewal
P304
P3181
P356
10.1146/ANNUREV.IMMUNOL.16.1.111
P407
P577
1998-04-01T00:00:00Z